DeAnna Friedman-Klabanoff

MedicinePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing”.

Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing

Vaccine(2021)10.1016/j.vaccine.2020.12.023

N/A

0.981DataRank · unranked

23 citations

Andrea A. Berry, Mark A. Travassos, Catherine Cox, Yingjun Zhou, Annie X. Mo +5 more

Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership

Vaccine X(2023)10.1016/j.jvacx.2023.100371

N/A

0.419DataRank · unranked

6 citations

Ashley H. Tjaden, Jone Renteria, DeAnna Friedman-Klabanoff, Amy Hinkelman, Michael Gibbs +11 more

Epitope-Specific Antibody Responses to a Plasmodium falciparum Subunit Vaccine Target in a Malaria-Endemic Population

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa611

N/A

0.405DataRank · unranked

7 citations

Mark A. Travassos, Olukemi O. Ifeonu, Sonia Agrawal, Amed Ouattara, Andrew Pike +16 more

Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae062

N/A

0.344DataRank · unranked

7 citations

Andrea A. Berry, Mark A. Travassos, Mallory Shriver, Catherine Cox, Jessica Butts +12 more

Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition Is Associated With Individual Exposure but Not Community-Level Transmission

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac029

N/A

0.241DataRank · unranked

4 citations

Meagan C. Fitzpatrick, Meagan E. Deming, Vaidehi Agrawal, Sandra Sitar, Torin Schaafsma +95 more

Factors associated with COVID-19 vaccination during June–October 2021: A multi-site prospective study

Vaccine(2023)10.1016/j.vaccine.2023.03.057

N/A

0DataRank · unranked

10 citations

Lida M. Fette, Amy Hinkelman, E. Adrianne Hammershaimb, DeAnna Friedman-Klabanoff, Morgana Mongraw‐Chaffin +10 more

Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial

EBioMedicine(2022)10.1016/j.ebiom.2022.104375

N/A

0DataRank · unranked

21 citations

Megan Birkhold, Mara Short, Timothy R. Wilson, Claudio Meneses, Joshua R. Lacsina +10 more

Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.48325

N/A

0DataRank · unranked

53 citations

Meighan Krows, Torin Schaafsma, Kate B. Heller, Elizabeth R. Brown, Jim Boonyaratanakornkit +19 more

Controlled human malaria infection with NF54 and 7G8 strains elicit differential antibody responses to Plasmodium falciparum peptides

Frontiers in Immunology(2025)10.3389/fimmu.2025.1641280

N/A

0DataRank · unranked

0 citations

Travis L. Jensen, Kirsten E. Lyke, Matthew B. Laurens, Joana C. Silva, Emily M. Stucke +15 more